Table 3:
Univariable analysis for an overall post-heart transplantation survival.
| Variables | Survivors (n = 57) | Non-survivors (n = 12) | P-value |
|---|---|---|---|
| Age (years) | 50 (41, 58) | 55 (42, 61) | 0.103 |
| Creatinine (µmol/l) | 79 (89, 104) | 99 (93, 139) | 0.014 |
| BUN (mmol/l) | 5.8 (4.3, 6.7) | 8.1 (6.1, 9.8) | 0.018 |
| GFR (ml/1.72 m2) | 110 (88, 129) | 107 (67, 112) | 0.053 |
| PASP before HMII implantation (mmHg) | 58 (45, 67) | 66 (53, 69) | 0.002 |
| TPG before HMII implantation (mmHg) | 10 (9, 14) | 14 (11, 19) | 0.023 |
| CVP before HMII implantation (mmHg) | 10 (6, 14) | 15 (10, 19) | 0.026 |
| HMII concomitant procedure (%) | 13 (22.8) | 6 (50) | 0.077 |
| HMII AVR (%) | 3 (5.3) | 5 (41.7) | 0.003 |
| HLA sensitized on HMII (%) | 22 (38.6) | 1 (8.3) | 0.048 |
| AT1R antibody conversion during HMII (%) | 39 (68.4) | 5 (41.7) | 0.149 |
BUN: blood urea nitrogen; GFR: glomerular filtration rate; PASP: pulmonary artery systolic pressure; TPG: trans-pulmonary gradient; CVP: central venous pressure; AVR: aortic valve replacement; HLA: human leucocyte antigen; AT1R: angiotensin II type 1 receptor; HMII: Heart Mate II.